What is CB1 Receptor?

The CB1 receptor (cannabinoid receptor type 1) is the most abundant G-protein coupled receptor in the human brain and a primary component of the endocannabinoid system. First cloned and characterized in 1990, CB1 receptors are predominantly found in the central nervous system, particularly in areas controlling memory, cognition, motor function, and pain perception. These receptors are densely concentrated in the hippocampus, cerebellum, basal ganglia, and cerebral cortex. Outside the brain, CB1 receptors are present in peripheral tissues including the liver, adipose tissue, and gastrointestinal tract, though in lower concentrations than CB2 receptors in these areas. CB1 receptors bind to endogenous cannabinoids (endocannabinoids) like anandamide and 2-arachidonoylglycerol, as well as phytocannabinoids from cannabis such as THC and CBD. When THC binds to CB1 receptors, it produces the characteristic psychoactive effects associated with cannabis consumption, including euphoria, altered perception, and impaired short-term memory. The binding affinity varies significantly among cannabinoids. THC has high affinity for CB1 receptors with a Ki value of approximately 5-80 nM, while CBD has much lower affinity (Ki > 1000 nM) and can actually act as a negative allosteric modulator, potentially reducing THC's psychoactive effects. Research indicates CB1 receptor density can be influenced by chronic cannabis use. Studies show that heavy users may experience downregulation of CB1 receptors, potentially contributing to tolerance development. However, these changes appear largely reversible with abstinence. Understanding CB1 receptors is crucial for cannabis product development, as the receptor's distribution explains why different cannabinoid ratios produce varying effects. This knowledge drives formulation strategies for both recreational and medical cannabis products targeting specific therapeutic outcomes. *This information is for educational purposes only and should not be considered medical advice. Consult healthcare professionals for medical guidance.*